OPKO Health (OPK) Misses Q4 EPS by 9c, Revenue Beats

OPKO Health (NASDAQ: OPK) reported Q4 EPS of ($0.11), $0.09 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $401.3 million versus the consensus estimate of $329.83 million.

For earnings history and earnings-related data on OPKO Health (OPK) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
• LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c